Yale University researcher Akiko Iwasaki, Ph.D., says immune profiling shows how Long COVID patients have distinct features not found in control groups. These patients, who also exhibit elevated levels of exhausted T-cells, cause her to express surprise at skeptics.
Iwasaki joins Fiona Lowenstein, editor of “The Long COVID Survival Guide,” to discuss patients who say they’re suffering from Long COVID for as much as two years after their acute phase of the disease.
Iwasaki also explains why her lab’s effort to move forward with a COVID nasal spray faces financial hurdles.
Listen in to this important conversation with hosts Mark Masselli and Margaret Flinter.
Podcast: Play in new window | Download
Subscribe: Apple Podcasts | Spotify | Android | Podchaser | TuneIn | RSS | More
Dr. Leana Wen, a health news commentator for The Washington Post and CNN, is known…
Very early this morning the U.S. House passed a bill that would result in more…
Originally broadcast May 15, 2025 Millions are still living with the effects of Long COVID…
Originally broadcast May 8, 2025 Skin cancer is the most common cancer in the United…
A recent survey surprisingly found only 41% of physicians were “very confident” about their ability…
Originally broadcast April 22, 2025 Health and Human Services Secretary Robert F. Kennedy Jr. announced…